Ads
related to: neurodegenerative dementia- About Treatment
Learn more about the Alzheimer's
treatment option & how it works.
- Alzheimer's Disease Info
Learn about the stages of AD and
diagnostic tests for patients.
- Support & Resources
Patient and care partner support
available on the treatment website.
- Sign Up For More Info
Get access to information all about
treatment & useful tips.
- Getting Started
Find infusion FAQs & tips for
getting started with treatment.
- For Care Partners
Help support your loved one. View
tips and infusion companion info.
- About Treatment
Search results
Startling Discovery: Young Diabetics Show Early Signs of Alzheimer’s Disease
SciTechDaily· 6 days agoA study from CU Anschutz indicates that diabetes beginning in youth may increase the risk of ...
Scripps Research Front Row Lecture
KPBS San Diego· 22 hours agoAll proteins have a correct way of “folding” themselves into their three-dimensional structures. When this folding process goes awry, including processes...
Consumption of Vitamins D and K May Keep Memory Diseases Away
Agricultural Research Magazine· 7 days agoTwo important nutrients, vitamins D and K, have been associated with a lower risk of conditions like...
Sleep does not help brain 'clear out toxins,' study suggests
Medical News Today· 13 hours agoA new study in mice suggests the hypothesis that brain-cleansing occurs during sleep may be...
What Does a Lonely Brain Look Like?
New York Times· 7 days agoFeeling chronically disconnected from others can affect the brain’s structure and function, and it raises the risk for neurodegenerative diseases. It...
Coya Therapeutics Reports First Quarter 2024 Financial Results
GuruFocus.com via Yahoo Finance· 5 days agoThe expansion of COYA 302 to address Frontotemporal Dementia, Parkinsons Disease, and Alzheimers Disease underscores the company's strategic intent to leverage its proprietary ...
Eating highly processed foods can cause early death, study finds
Scripps News via AOL· 6 days agoWhile most studies have found links to cardiovascular disease and cancer, researchers in this study...
New hospital will add 150 psychiatric beds in Seattle
Seattle Times· 16 hours agoAbout two dozen health care workers crowded around tables on a recent Thursday to troubleshoot the...
Eisai initiates rolling Biologics License Application to US FDA for Leqembi® (lecanemab-irmb) for...
WROC Rochester· 1 day agoIn the US, Leqembi is indicated for the treatment of Alzheimer's disease (AD) in patients with Mild...
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
Digital Journal· 1 day agoTop-line data from first-in-human Phase 1a clinical trial of PMN310 as a treatment for Alzheimer’s disease on track for mid-2024CAMBRIDGE, Massachusetts and TORONTO, Ontario, May 14, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a
Ad
related to: neurodegenerative dementia
